Brenda Y. Hernandez to Melanoma
This is a "connection" page, showing publications Brenda Y. Hernandez has written about Melanoma.
Connection Strength
0.586
-
Chtourou A, Sanchez PV, Golden T, Chen HS, Schwartz SM, Wu XC, Hernandez BY, Harrison JN, Penberthy L, Negoita S. Impact on the Volume of Pathology Reports Before and During the COVID-19 Pandemic in SEER Cancer Registries. Cancer Epidemiol Biomarkers Prev. 2023 11 01; 32(11):1591-1598.
Score: 0.211
-
Bailey CN, Martin BJ, Petkov VI, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gomez SL, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura MJ, Schwartz SM, Ward KC, Wiggins C, Wu XC, Goldberg MS, Siegel JJ, Cook RW, Covington KR, Kurley SJ. 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration. JCO Precis Oncol. 2023 06; 7:e2300044.
Score: 0.205
-
Robbins HA, Clarke CA, Arron ST, Tatalovich Z, Kahn AR, Hernandez BY, Paddock L, Yanik EL, Lynch CF, Kasiske BL, Snyder J, Engels EA. Melanoma Risk and Survival among Organ Transplant Recipients. J Invest Dermatol. 2015 Nov; 135(11):2657-2665.
Score: 0.120
-
Hernandez BY. Highlights of recent cancer incidence data in Hawaii. Hawaii Med J. 2003 Jan; 62(1):17-8.
Score: 0.050